Cargando…
‘Advocacy groups are the connectors’: Experiences and contributions of rare disease patient organization leaders in advanced neurotherapeutics
INTRODUCTION: Biomedical progress has facilitated breakthrough advanced neurotherapeutic interventions, whose potential to improve outcomes in rare neurological diseases has increased hope among people with lived experiences and their carers. Nevertheless, gene, somatic cell and other advanced neuro...
Autores principales: | Nguyen, Christina Q., Kariyawasam, Didu, Alba‐Concepcion, Kristine, Grattan, Sarah, Hetherington, Kate, Wakefield, Claire E., Woolfenden, Susan, Dale, Russell C., Palmer, Elizabeth E., Farrar, Michelle A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700154/ https://www.ncbi.nlm.nih.gov/pubmed/36307981 http://dx.doi.org/10.1111/hex.13625 |
Ejemplares similares
-
“We needed this”: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy
por: Kariyawasam, Didu S.T., et al.
Publicado: (2021) -
Role of multidrug transporters in neurotherapeutics
por: Jose, Manna, et al.
Publicado: (2009) -
Neurotherapeutics for ADHD: Do they work?
por: Rubia, Katya
Publicado: (2022) -
Editorial: Glaucoma: In Search of Better Neurotherapeutics
por: Russo, Rossella, et al.
Publicado: (2018) -
Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)